Agios sells rights to glioma drug to Roy­al­ty Phar­ma; Car­go’s $110M place­ment

Plus, news about Turn Biotech­nolo­gies, HanAll Bio­phar­ma, Cor­cept Ther­a­peu­tics, Ac­tu­ate and Mer­ck:

Agios sells vo­rasi­denib rights to Roy­al­ty Phar­ma: As part of the agree­ment, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER